- Home
- IBIO vs TRT Comparison
IBIO vs TRT Comparison
Compare IBIO & TRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBIO
- TRT
- Stock Information
- Founded
- IBIO 2008
- TRT 1958
- Country
- IBIO United States
- TRT United States
- Employees
- IBIO N/A
- TRT N/A
- Industry
- IBIO Biotechnology: Pharmaceutical Preparations
- TRT Industrial Machinery/Components
- Sector
- IBIO Health Care
- TRT Technology
- Exchange
- IBIO Nasdaq
- TRT Nasdaq
- Market Cap
- IBIO 24.3M
- TRT 24.7M
- IPO Year
- IBIO N/A
- TRT N/A
- Fundamental
- Price
- IBIO $2.83
- TRT $5.85
- Analyst Decision
- IBIO Strong Buy
- TRT
- Analyst Count
- IBIO 3
- TRT 0
- Target Price
- IBIO $4.87
- TRT N/A
- AVG Volume (30 Days)
- IBIO 132.6K
- TRT 8.5K
- Earning Date
- IBIO 02-07-2025
- TRT 02-10-2025
- Dividend Yield
- IBIO N/A
- TRT N/A
- EPS Growth
- IBIO N/A
- TRT N/A
- EPS
- IBIO N/A
- TRT 0.13
- Revenue
- IBIO $175,000.00
- TRT $42,145,000.00
- Revenue This Year
- IBIO N/A
- TRT N/A
- Revenue Next Year
- IBIO N/A
- TRT N/A
- P/E Ratio
- IBIO N/A
- TRT $45.24
- Revenue Growth
- IBIO 250.00
- TRT 2.10
- 52 Week Low
- IBIO $1.02
- TRT $4.94
- 52 Week High
- IBIO $4.98
- TRT $7.88
- Technical
- Relative Strength Index (RSI)
- IBIO 61.21
- TRT 39.90
- Support Level
- IBIO $2.40
- TRT $5.74
- Resistance Level
- IBIO $2.93
- TRT $6.10
- Average True Range (ATR)
- IBIO 0.19
- TRT 0.20
- MACD
- IBIO 0.04
- TRT 0.02
- Stochastic Oscillator
- IBIO 83.87
- TRT 46.03
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
About TRT Trio-Tech International
Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.